UNSPSC 51421605: Clobetasol propionate

This classification denotes a therapeutic glucocorticoid with the molecular formula C25H32ClFO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 779619577M, chemically known as 21-chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione (11beta,16beta)- but more generally known as clobetasol propionate, which bears US NIH Compound Identifier 32798. European Medicines Agency schedules Clobetasol propionate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01346MIG.

UNSPSC 51421605 Clobetasol propionate is a Commodity code for a topical corticosteroid pharmaceutical, but the recent state and local procurement activity tagged under this code does not reflect pharmaceutical purchases. Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually — a public health procurement unrelated to clobetasol propionate. The mismatch suggests either a miscoding in the county's taxonomy system or an isolated tagging error; the code shows no other recent state or local opportunities aligned with its nominal pharmaceutical scope.

The single recorded opportunity under this code is Seminole County's drug-harm-reduction procurement, which calls for quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a fixed-fee award structure and a two-year initial term plus one-year renewal option. Bidders must comply with federal requirements including E-Verify, drug-free workplace certification, and potential FEMA compliance obligations. No other issuing bodies or geographic markets post under this code in the available recent-opportunities record, and no explicit set-aside designations appear in the solicitation. The code exhibits minimal recent state and local procurement activity relevant to its pharmaceutical classification.